mycophenolate mofetil

mycophenolate mofetil
Clinical data
Pronunciation	/ˌmaɪkoʊfɪˈnɒlɪk/
Trade names	Cellcept, Myfortic, Myhibbin, others
Other names	MPA, Mycophenolate sodium, Mycophenolate mofetil (AAN AU), Mycophenolate mofetil (USAN US)
AHFS/Drugs.com	Monograph
MedlinePlus	a601081
License data	US DailyMed: Mycophenolate mofetil;
Pregnancy; category	AU: D;
Routes of; administration	By mouth, intravenous
ATC code	L04AA06 (WHO) ;
Legal status
Legal status	AU: S4 (Prescription only); CA: ℞-only; UK: POM (Prescription only); US: ℞-only; EU: Rx-only; In general: ℞ (Prescription only);
Pharmacokinetic data
Bioavailability	72% (sodium),; 94% (mofetil)
Protein binding	82–97%
Metabolism	Liver
Elimination half-life	17.9±6.5 hours
Excretion	Urine (93%),; faeces (6%)
Identifiers
	IUPAC name (4E)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydro-2-benzofuran-5-yl)-4-methylhex-4-enoic acid;
CAS Number	24280-93-1 ;
PubChem CID	446541;
IUPHAR/BPS	6832;
DrugBank	DB01024 ;
ChemSpider	393865 ;
UNII	HU9DX48N0T;
KEGG	D05096 ;
ChEBI	CHEBI:168396 ;
ChEMBL	ChEMBL866 ;
Chemical and physical data
Formula	C17H20O6
Molar mass	320.341 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O=C1OCc2c1c(O)c(c(OC)c2C)C\C=C(/C)CCC(=O)O;
	InChI InChI=1S/C17H20O6/c1-9(5-7-13(18)19)4-6-11-15(20)14-12(8-23-17(14)21)10(2)16(11)22-3/h4,20H,5-8H2,1-3H3,(H,18,19)/b9-4+ ; Key:HPNSFSBZBAHARI-RUDMXATFSA-N ;
	(what is this?) (verify)